mehboubi. mr. mehboubi , i am at your service, mr. bai, and dear listeners and viewers whom we are serving. yes, mr. mahboubi as an opposition is actually this plan . mr. mahboubi, do you have something to say, please tell me because we have heard your explanation, if i may. please, i will skip the legal cases. we have about 15 cases of legal violations in this case . i will go back to a root issue. health has expressed a clear opinion on the issue of platforms and stated that everyone in the discussion of platforms is now operating in a legal way and did not act and it is an act. therefore, each and every product that is being sold to the people from this route until now , from my point of view as a pharmaceutical doctor and from the point of view of the ministry of health as the responsible body for supervising the product, is considered an unauthorized product for the purpose of this article . let's take another look at the law. look, our friend is discussing legal issues, our opposite opinion is from the point of view of health an

mehboubi, mr.boubi, please give your closing comment, i said it is very short because we don't have time, i will give you a minute, not your minute, you all spoke , i need one minute, mr. hosseini i have a minute of opportunity, sir, with a sarkowe until this moment . from the law, by concealing and hiding the details of the people with whom they work in the drug trade, so i think that they have the authority to continue this activity or not, our government men. our people should judge. thank you very much, mr. mehboobi . you have a short time. they are eager for this issue to find a logical order and all the standards will be determined. well, mr. fatemi, in fact , the next opponent, please see the final comment. according to article 20 of the health and pharmaceutical affairs supervision law, the institution of the ministry of health, the organization of the medical system , the association of pharmacists is responsible for dealing with violations they are in charge of the medicine, this is what